| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.28B | +40.2% |
| Cost of Revenue | $985.6M | +59.4% |
| Gross Profit | $298.6M | +0.3% |
| R&D Expense | $9.9M | +47.8% |
| SG&A Expense | $198.6M | +23.7% |
| Operating Income | -$29.0M | +87.2% |
| Pre-tax Income | -$29.2M | +88.3% |
| Income Tax | $23.0M | +326.1% |
| Net Income | -$52.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $244.4M | -32.7% |
| Accounts Receivable | $271.6M | -1.5% |
| Inventory | $150.4M | -25.1% |
| Current Assets | $869.0M | -13.0% |
| Total Assets | $1.45B | +1.8% |
| Current Liabilities | $377.0M | -13.9% |
| Long-term Debt | $658.7M | +1.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $101.8M | -33.9% |
| Capital Expenditures | $22.0M | +200.8% |
| Investing Cash Flow | -$187.9M | -1862.9% |
| Financing Cash Flow | -$38.1M | -221.3% |
| Free Cash Flow | $79.8M | -45.6% |
| +78.3% |
| EPS (Basic) | -$0.73 | +62.6% |
| EPS (Diluted) | -$0.73 | +62.6% |
| Total Liabilities |
| $1.19B |
| +4.8% |
| Stockholders' Equity | -$206.3M | -74.7% |